Two-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitors
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our current antimalarial therapies, including artemisinin combination therapies which are widely described as our last line of defense. Antimalarial agents with a novel mode of action are urgently required. T...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
American Chemical Society
2014
|
| Online Access: | https://eprints.nottingham.ac.uk/30418/ |